CAMBIUM ONCOLOGY
Cambium Oncology LLC is a pre-clinical start-up focused on developing and commercializing new immuno-oncology therapeutics that target a novel checkpoint pathway. The company has licensed a patented technology from Emory University to use inhibitory peptides designed against immuno-suppressive vasoactive intestinal peptide (VIP) to cause both in vitro and in vivo activation and proliferation of T cells. Administration of VIP-antagonist peptides trigger a robust cytotoxic T-cell mediated immune response in tumor-bearing animals that resulted in reduction of tumor size and increase in survival time.
CAMBIUM ONCOLOGY
Industry:
Clinical Trials Health Care
Founded:
2018-01-01
Address:
Atlanta, Georgia, United States
Country:
United States
Website Url:
http://www.cambiumoncology.com
Status:
Active
Contact:
404-693-7796
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Sitelinks Search Box
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.cambiumoncology.com
- Host name: 143.198.66.95
- IP address: 143.198.66.95
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
